Could scorpion venom inspire new treatments for liver disease?
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…
Microbial metabolites could help improve functional cure rates for hepatitis B
Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure…
Modeling the synergy of maternal screening and newborn HBV vaccination
Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, including chronic…
Dynamic viral markers predict treatment response in hepatitis B
Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in…
Combination strategy may optimize interferon-based therapy for chronic hepatitis B
Background and objectives Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen…
Postpartum mothers more likely to be cured of hepatitis C with bedside treatment
Hepatitis C, a bloodborne virus that damages the liver, can cause cirrhosis, liver cancer, liver failure and death…